Comparing treatment strategies for heart failure: a real-world analysis of adding ARNI or SGLT2i to older GDMT

被引：0
|
作者：
Amornritvanich, P. [1 ]
Numthavaj, P. [1 ]
Anothaisintawee, T. [1 ]
Tansawet, A. [2 ]
Thakkinstian, A. [1 ]
机构：
[1] Mahidol Univ, Ramathibodi Hosp, Bangkok, Thailand
[2] Navamindradhiraj Univ, Fac Med Vajira Hosp, Dept Surg, Bangkok, Thailand
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.1221
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Risk of diabetic microvascular complications, heart failure, hospitalisation and all-cause mortality with SGLT2i and GLP1-ra in type 2 diabetes: a real-world data study
    Eleftheriadou, A.
    Riley, D.
    Austin, P.
    Hernandez, G.
    Alam, U.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S74 - S74
  • [42] Four-year use of SGLT2i as adjunctive therapy in adults with type 1 diabetes: a real-world experience
    Valenzano, Marina
    Massari, Louis
    Abrate, Paolo
    Marinazzo, Elisa
    Allasia, Stefano
    Gatto, Valentina
    Zinetti, Elena
    Fornengo, Riccardo
    ACTA DIABETOLOGICA, 2025,
  • [43] Relationship between initial eGFR DIP with proteinuria after SGLT2i treatment, in patients with IgA nephropathy. A real-world clinical study
    Xydakis, Dimitris
    Antonaki, Ergini
    Tzali, Eleni
    Papapanagiotou, Michalis
    Petra, Christina
    Kostakis, Kostantinos
    Vardaki, Eleftheria
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [44] Referral to a Heart Failure Clinic Substantially Increases the Use of Angiotensin Receptor Neprilysin Inhibitor (ARNi) and Sodium-glucose cotransporter-2 Inhibitor (SGLT2i) in Heart Failure Patients.
    Baksh, Gladys
    Ali, Omaima
    Haydo, Michele
    Velasco, Claudia Mae
    Reesor, Heather
    CIRCULATION, 2024, 150
  • [45] Patient characteristics and drug utilization of heart failure patients prescribed SGLT2i and sacubitril/valsartan, a real-world database cohort study of Optum electronic health record data source
    Loefroth, E.
    Hughes, M.
    Wang, Y.
    Shi, Y.
    Proudfoot, C.
    Di Domenico, M.
    Modgill, V.
    Schlienger, R.
    Studer, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 273 - 273
  • [46] Response to the Nephrological perspectives on the underutilization of SGLT2i in heart failure and chronic kidney disease
    Kocabas, Umut
    ESC HEART FAILURE, 2025,
  • [47] Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients
    Michele Correale
    Olga Lamacchia
    Michele Ciccarelli
    Giuseppe Dattilo
    Lucia Tricarico
    Natale Daniele Brunetti
    Heart Failure Reviews, 2023, 28 : 733 - 744
  • [48] Response to the Nephrological perspectives on the underutilization of SGLT2i in heart failure and chronic kidney disease
    Kocabas, Umut
    ESC HEART FAILURE, 2025, 12 (02): : 1492 - 1493
  • [49] SGLT2i and Deterioration of Kidney Function in Heart Failure Another Demonstration for Tolerance of "Hypercreatininemia"
    Coca, Steven G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (19) : 1864 - 1867
  • [50] Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients
    Correale, Michele
    Lamacchia, Olga
    Ciccarelli, Michele
    Dattilo, Giuseppe
    Tricarico, Lucia
    Brunetti, Natale Daniele
    HEART FAILURE REVIEWS, 2023, 28 (03) : 733 - 744
12345